↓ Skip to main content

Outlook on PI3K/AKT/mTOR inhibition in acute leukemia

Overview of attention for article published in Molecular and Cellular Therapies, March 2015
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age

Mentioned by

twitter
1 X user

Citations

dimensions_citation
110 Dimensions

Readers on

mendeley
89 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Outlook on PI3K/AKT/mTOR inhibition in acute leukemia
Published in
Molecular and Cellular Therapies, March 2015
DOI 10.1186/s40591-015-0040-8
Pubmed ID
Authors

Lars Fransecky, Liliana H Mochmann, Claudia D Baldus

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 89 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Germany 1 1%
Brazil 1 1%
Unknown 87 98%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 22 25%
Researcher 12 13%
Student > Master 12 13%
Student > Bachelor 11 12%
Other 7 8%
Other 12 13%
Unknown 13 15%
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 27 30%
Medicine and Dentistry 13 15%
Agricultural and Biological Sciences 13 15%
Mathematics 4 4%
Immunology and Microbiology 4 4%
Other 11 12%
Unknown 17 19%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 18 June 2023.
All research outputs
#17,633,850
of 25,845,895 outputs
Outputs from Molecular and Cellular Therapies
#28
of 38 outputs
Outputs of similar age
#170,572
of 278,658 outputs
Outputs of similar age from Molecular and Cellular Therapies
#2
of 2 outputs
Altmetric has tracked 25,845,895 research outputs across all sources so far. This one is in the 21st percentile – i.e., 21% of other outputs scored the same or lower than it.
So far Altmetric has tracked 38 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 15.1. This one scored the same or higher as 10 of them.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 278,658 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 30th percentile – i.e., 30% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 2 others from the same source and published within six weeks on either side of this one.